International News
DRDO issues directions for the usage of anti-Covid drug 2-DG on patients
The Defense Research and Development Organization (DRDO) on Tuesday issued guidelines on how and when to use its anti-Covid drug 2-deoxy-D-glucose (2-DG) drug.
The drug was launched by the Defense Ministry last month. It has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a premier laboratory of DRDO, in collaboration with Dr Reddy’s Laboratories (DRL) in Hyderabad.
DRDO said that the 2-DG drug should be used under the supervision of a doctor. Oral medication for emergency use is an adjunctive therapy for the treatment of severe COVID patients. It reduces dependence on supplemental oxygen.
2-DG. Directions for use:
- 2DG should be prescribed by doctors early. The drug can be prescribed for up to 10 days and the recipients can be both moderate to severe COVID patients.
- This drug is approved for ’emergency use’, and can be used as adjunctive therapy along with the standard procedure followed in the treatment of a COVID patient.
- 2DG has not yet been tested in patients with uncontrolled diabetes, severe cardiac problems, ARDS, severe hepatic and renal impairment. So extra caution is needed.
- Lactating and pregnant women should not be prescribed with 2DG, and the same applies to people under 18 years of age.
- Patients/attendants wishing to purchase 2DG medicine should email their requirements to 2DG@drreddys.com. This email id belongs to Dr. Reddy’s Lab, Hyderabad.
The drug was approved by the Drug Controller General of India (DCGI) on May 1 for emergency use as adjunctive therapy in moderate to severe COVID-19 patients. Defense Minister Rajnath Singh and Health Minister Harsh Vardhan released the first batch of indigenously developed anti-COVID-19 drugs on 17 May.
The price of DRDO’s 2DG anti-COVID-19 drug has been fixed by pharma major Dr. Reddy’s Laboratories at Rs 990 per pouch. However, the medicine will be made available by the government hospitals at a subsidized price. According to Dr. Reddy’s Laboratories, the drug will be launched commercially in mid-June.
News Source: HindustanTimes
Web Series
HBO defends JK Rowling’s involvement in Harry Potter series despite problematic stance on transgender community
JK Rowling, whose Harry Potter book franchise gave Warner Bros a blockbuster film franchise, is also associated with its upcoming HBO series.
JK Rowling has remained decidedly steadfast on her controversial stance on the transgender community. In a statement to Variety, HBO explained why the author is still involved in its upcoming series on Harry Potter despite her problematic gender politics. (Also Read: This Oscar-nominated actor lost out on Luna Lovegood role in Harry Potter, says how it ‘stayed with me over the years’)
What HBO said
“We are proud to once again tell the story of Harry Potter — the heartwarming books that speak to power of friendship, resolve and acceptance. JK Rowling has a right to express her personal views. We will remain focused on the development of the new series, which will only benefit from her involvement,” HBO’s statement stated.
It also added that its parent company Warner Bros “been working with JK Rowling and in the Harry Potter business for over 20 years” and “her contribution has been invaluable.” The report also states that HBO chief Casey Bloys informed the media at an event on November 12 that JK Rowling was “very, very involved in the process selecting the writer and the director,” and her anti-trans statements “haven’t affected the casting or hiring of writers or productions staff.”
A couple of days before that, Rowling had shared a screenshot of a tweet by an X user who wrote, “My disappointment is immeasurable and my day is ruined” when the author had revealed that she’s “very involved” in the Harry Potter series. Rowling wrote along with the screenshot, “I’ve only just seen this response to me saying I’m very involved in the Harry Potter TV show and I think I’ve pulled something laughing.”
About Harry Potter series
Warner Bros launched an open casting call for the leads Harry, Hermoine and Ron, who were played by Daniel Radcliffe, Emma Watson and Rupert Grint, respectively, in the eight-part movie franchise.
The series will most likely go ahead with newcomers for the top three characters and mix it with veterans for the adult cast, like the movie franchise, which featured Richard Harris as Dumbledore and roped in Michael Gambon after his death. Late star Maggie Smith played Professor McGonagall, and Alan Rickman starred as Professor Snape.
Mark Rylance, 64, who won an Academy Award for best supporting actor in 2016 for his work in Steven Spielberg’s Bridge of Spies, is reportedly at the top of the casting wishlist to play Dumbledore in the Harry Potter series.
Group Media Publications
Entertainment News Platforms – anyflix.in
Construction Infrastructure and Mining News Platform – https://cimreviews.com/
General News Platform – https://ihtlive.com/
-
india1 month ago
‘My support will be with new J&K govt’: L-G Manoj Sinha ahead of Omar Abdullah’s oath-taking ceremony
-
Politics1 month ago
New BJP government to take oath in Haryana on Oct 17, PM Modi to attend
-
Sports1 month ago
Score for the third day of the first test between India and New Zealand: Ravindra-Southee crushes IND, NZ leads by 299 at lunch
-
TV1 month ago
Prince Narula and Yuvika Chaudhary share first pic with newborn daughter from hospital. See post
-
In News2 weeks ago
SpiceJet announces 8 new flights to connect Jaipur with Varanasi, Amritsar and Ahmedabad
-
Business2 weeks ago
OpenAI buys new domain chat.com for over $15 million, it redirects to ChatGPT
-
Entertainment.1 month ago
Massive data breach at Game Freak studios reveals shocking new dark Pokemon movie plot
-
World News1 day ago
Who is Harun Abdul-Malik Yener? Florida man arrested over bomb threat to New York Stock Exchange